rood blauwe elepsis logo Belegger.nl

Amerikaanse aandelen Terug naar discussie overzicht

Pacific Ethanol Inc (Public, NASDAQ:PEIX)

6.395 Posts
Pagina: «« 1 ... 6 7 8 9 10 ... 320 »» | Laatste | Omlaag ↓
  1. h980577. 7 juni 2011 21:24
    Ha Roos,

    Wat dacht je hiervan? :)

    Reconstitution schedule
    June 10
    Preliminary additions and deletions to the Russell Global, Russell 3000® and Russell Microcap® Indexes published after 3:00 p.m. PST June 17
    Updates to the list of additions and deletions June 24
    Updates to the list of additions and deletions

    Reconstitution final after the close of the U.S. markets June 27
    Final membership lists posted for the Russell Global, Russell 3000, Russell 1000®, Russell 2000®, Russell Midcap® and Russell Microcap Indexes

    www.russell.com/indexes/tools-resourc...

    PS morgen reverse split van 1 nieuw aandeel PEIX voor 7 oude... Dan maar eens afwachten of de slachting stopt. 10 dagen boven de USD 1,- is het doel in ieder geval :)
  2. [verwijderd] 7 juni 2011 22:24
    hahaha u weet het nog! RUSSELL! ;-)

    ik zal hem eens even bekijken...

    en wat betreft peix... hij staat wel erg laag he.. wellicht de split even afwachten en dan even kijken of ie nog verder down gaat...
    heb verder de berichten ook niet gevolgd...las inderdaad vanmiddag ook over die split morgen.

  3. h980577. 20 juni 2011 21:11
    Morgen 10 dagen een bid hoger dan USD 1,-, dus dan is het risico op een delisting van de Nasdaq (voorlopig) voorbij.

    Wel lijkt er inmiddels een wat meer positief momentum te ontstaan.
    (voor als je een sterk hart hebt misschien gokje waard)

    Voorbeeld vandaag, +25%, half uur later onveranderd, nu weer 10% hoger
    Voorbeeld vorige week: +40% gedurende de dag, slot was nog maar 10% hoger....

  4. h980577. 18 juli 2011 21:35
    en inmiddels kunnen we weer aftellen naar de volgende split, USD 0,98 momenteel.

    zou dag 3 alweer betekenen met een bid van minder dan USD 1.- op slotbasis.

  5. h980577. 9 augustus 2011 19:20
    After Months of Decline is a Leveling Out at Hand?By Dennis Askew
    Published: August 9, 2011 9:19:27 AM PDT
    SharePrint Email 0 Comment(s) - Post a Comment
    Rating N/AStockHQ:PEIX $0.60 -$0.03 -4.60%
    After months of taking a beating, Pacific Ethanol Inc (NASDAQ: PEIX) might finally be coming to a bottom to rally from. There have two major factors in the stocks decline from $7 at the beginning of the year…

    The first significant enemy was the ‘Green’ industry as a whole lagging behind its maternal parent the ‘Energy’ sector which has had its ups and downs in the last eight months. A minor factor was the volatility of commodity prices, like corn (and cotton) making base prices in production unstable, and generally making products more expensive to produce.

    Then along came the second major factor plaguing Pacific Ethanol Inc (NASDAQ: PEIX) which was the broader markets decline as a whole and global exports from the U.S. getting smaller and smaller.
    So down the shares went, in a long, painful, textbook loss.

    Then a 3 for 1 reverse split to get the stock back to a $1 listing required by the exchange really took the breath away from any shareholder confidence to buy more shares of Pacific Ethanol Inc (NASDAQ: PEIX) if only for the sake of aggregating towards a lesser cost price in case of a possible forced sale; like news or rumors of a possible bankruptcy.

    Management has done some offensive posturing to reduce the speed of the fall, like constantly, and wherever it was possible, amending its debt to reduce its impact on the bottom line. Those measures and a late July Q2 report with Y-O-Y Q2 net sales growing 180%, revenues up 143% over Q2 ’10, and total gallons sold Y-O-Y Q2 increasing 54% appeared to keep morale alive. The stock traded flat at $1 through most of July.

    The shares the suffered the wrath of the broader markets tanking and Pacific Ethanol Inc (NASDAQ: PEIX) traded down to its current range of $0.62. The good news here is that it seems to have found some resistance at that level. The Company has the average number of short sellers, so they aren’t to blame here. The culprits are the ‘Green’ revolution winding up on the back pages of the news and panicky global markets.

    Hopefully, and one can only hope, this western based ethanol producer and supplier has seen its worst days and discussions of a national energy policy will come about again and give the share valuation some support. The question is can it hold $0.62 and then stage a rally?

    I haven’t, don’t, and do not intend on holding the company mentioned in this article
  6. p/o 26 oktober 2011 23:05
    cijfers zijn prachtig, 0.12 cent winst per aandeel voor dit kwartaal.

    Peix: 0.3401

    After Hours: 0.439 + 29.08%

    Pacific Ethanol, Inc. On Wednesday October 26, 2011, 4:10 pm
    • Achieved record net sales and total gallons sold for the quarter
    • Sequential net sales growth of 27%
    • Sequential increase in total gallons sold of 22%
    • Grew operating income to $4.7 million from $1.2 million in the third quarter of 2010
    • Increased EPS to $0.12 from a loss of $1.10 in the third quarter of 2010
    • Improved Adjusted EBITDA to $2.9 million from $0.9 million in the third quarter of 2010
    • Provides update on its senior convertible notes
    SACRAMENTO, Calif., Oct. 26, 2011 (GLOBE NEWSWIRE) -- Pacific Ethanol, Inc. (Nasdaq:PEIX - News), the leading marketer and producer of low-carbon renewable fuels in the Western United States, reported its financial results for the three- and nine-month periods ended September 30, 2011.
    Neil Koehler, the company's president and CEO, stated: "In the third quarter, we again delivered record net sales and total gallons sold driven by the continued execution of our diversified business strategy. We recorded the ninth consecutive quarter of growth in total gallons sold, bringing our compound annual growth rate to 75 percent over that period. Most importantly, we generated strong operating income and achieved profitability during the quarter. Further building on our growth strategy, after the close of the quarter, we secured a management agreement with ZeaChem that leverages our expertise in renewable fuel production to operate and maintain its cellulosic biorefinery. This agreement is significant in that it represents our first operations and maintenance arrangement beyond the Pacific Ethanol plants."
    Financial Results for the Three Months Ended September 30, 2011
    Net sales were at an all-time high of $271.6 million for the third quarter of 2011, compared to $46.0 million for the third quarter of 2010. Total gallons sold were 122.6 million for the third quarter of 2011, a sequential increase of 22% from the second quarter of 2011 and an increase of 71% over the 71.5 million gallons sold in the third quarter of 2010. The increase in net sales was primarily driven by the fact that the company did not consolidate the results of the Pacific Ethanol plants in the third quarter of 2010. The increase in total gallons sold was primarily due to continued strength in the company's marketing business and a 54% increase in average sales price per gallon. In addition, the company's third quarter 2011 results include the impact of the Stockton plant's operations whereas it was idled during the third quarter of 2010.
    Gross profit was $8.2 million for the third quarter of 2011, compared to $4.0 million in the third quarter of 2010. The increase in gross profit was attributable to an improved commodity margin environment and the contribution from the three Pacific Ethanol plants that were operational during the period. SG&A expenses, including professional fees, were $3.5 million in the third quarter of 2011, compared to $2.7 million for the third quarter of 2010, with the increase primarily due to the consolidation of the Pacific Ethanol plants. Operating income for the third quarter of 2011 increased to $4.7 million from $1.2 million for the same period in 2010 primarily due to an improved commodity margin environment.
    During the third quarter of 2011, the company recorded aggregate non-cash gains of $4.1 million for quarterly fair value adjustments on its convertible notes and warrants.
    Net income available to common stockholders for the third quarter of 2011 was $4.0 million, compared to a net loss of $12.9 million for the third quarter of 2010, which included a loss on the company's investment in Front Range Energy, LLC of $12.1 million. Adjusted EBITDA, which excludes the company's fair value adjustments on its convertible notes and warrants and loss on its investment in Front Range Energy, LLC, improved to $2.9 million for the third quarter of 2011 from $0.9 million in the third quarter of 2010.
    Financial Results for the Nine Months Ended September 30, 2011
    For the nine months ended September 30, 2011, net sales were $659.4 million, compared to $194.1 million in the same period in 2010…

  7. p/o 28 oktober 2011 22:27
    Gisteren meer dan 21 miljoen aandelen en het aandeel stijgt apmper, daarna laten ze mij panikeren zodat ik alles verkoop aan 0.388 en dan stijgt het tot 0.46 GGRRRRRRRRRR.
  8. h980577. 29 oktober 2011 11:50
    Ze zijn nog steeds het laatste deel van de converteerbare schuld aan het omzetten in aandelen he...dan zullen ze de koers echt niet zomaar loslaten.

    Btw, gezien de omzetten van de laatste paar dagen (ook tijdens voor en nabeurshandel) zou er zomaar eens een persbericht kunnen komen dat dit verwateren is afgelopen.

    Dat zou al heel wat verkoopdruk in ieder geval wegnemen.

    Gezien mijn verlies zou dat heeeeel wenselijk zijn :)

    Moeilijke is alleen dat ze nu al 2 kwartalen break even zijn, waarbij de vraag is of dat de top is of dat ze echt winstgevend kunnen worden en blijven op de lange termijn. (winst dit kwartaal was door incidentele bate)

    Voorlopig helpt de eur/dollar niet echt mee voor de waarde vd aandelen.

    Succes ermee!
  9. [verwijderd] 30 oktober 2011 22:24
    Pacific Ethanol Has Turned Around

    Pacific Ethanol Inc. (PEIX), one of the largest producers of ethanol in the U.S., just reported that in its just-completed September quarter revenues rose 490% year-over-year to $272 million from $46 million last September quarter, and earnings came in at 12c versus 3c in the prior June quarter, and a 6c loss in the prior year September quarter. The current quarter includes an aggregate non-cash gain of $4.1 million for quarterly fair value adjustments of its convertible notes and warrants, and after taking that and other unusual items out, the company would still be reporting positive earnings of just below 1c. While this is not as good as the headline of 12c, sequentially it is a big improvement over the 13c loss in the prior June quarter after taking out unusual items, and the 4c loss in the March quarter.

    PEIX also reported operating income of $4.7 million in the September quarter, which again is a big improvement over the $2.8 million and $1.6 million operating losses that it reported in the sequentially prior June 2011 and March 2011 quarters, as well as the $1.2 million it reported in the prior year September quarter. Adjusted EBITDA for the September quarter improved to $2.9 million, a big improvement over the $1.2 million and $1.5 million in the June and March 2011 quarters, as well as the $0.9 million in the prior year September quarter. Furthermore, as a historical comparison, PEIX traded in the $250 million market-cap range in 2008 prior to the recent bankruptcy and re-organization, when revenues were in the $150-$200 million range, and they had negative operating income. Their current market-cap in the $10-$20 million range seems much cheap by comparison given the improving fundamentals quarter-over-quarter, sales at $272 million in the latest quarter, and positive operating income and earnings.

    There has been no Wall Street analyst coverage on the stock since the company went through bankruptcy and emerged under a plan of reorganization in June last year. However, Zacks Investment Research does have a proprietary research report that was recently updated on October 4 prior to the current quarter report. While the full report can be accessed only by subscription at Zacks.com, the firm did put out an analyst blog last month that summarized their Outperform rating and $3 price target based on fundamentals prior to the reporting of their September quarter yesterday.
    Furthermore, insiders have been heavy buyers, with President and CEO Neil Koehler buying 150,000 shares, CFO Bryon McGregor buying 15,000 shares, and Director Michael Kandris buying 10,000 shares, all in the open market since June; no insiders have sold PEIX stock this year.

    Na me verdiept te hebben in dit aandeel het volgende,
    De meesten zijn hier nu gefocust op de kwartaalwinst, maar wat belangrijker is is de ongelooflijke omzetstijging waardoor de winst ook wel eens explosief kan gaan groeien in de komende kwartalen!
    Nu amper een k/w van 1 cent, dat zou wel eens heel snel 1 dollar kunnen worden met zo'n omzet!
    Uitstaande aandelen momenteel ruim 40 miljoen!

    Hopelijk kan ik ze maandag nog gunstig kopen, ik verwacht dat dit aandeel binnen zeer korte tijd tussen de 1 en 2 dollar zal staan!
  10. [verwijderd] 31 oktober 2011 13:39
    quote:

    drulletje drie schreef op 31 oktober 2011 11:56:

    Madera plant gaat ook weer open in Q1 2012!!
    Ze moeten meer gaan produceren dus ik denk dat het er voorlopig goed uitziet voor PEIX!
    www.dtnprogressivefarmer.com/dtnag/co...
    Zoals het er nu uit ziet opent het al zo'n 10% hoger, maar ik stap gewoon in, verwacht een verdubbeling binnen no time!
  11. [verwijderd] 2 november 2011 15:49
    quote:

    geefhetstockjenogmaareenkeerdoor schreef op 2 november 2011 14:56:

    Heb 20K binnen op 0.4681. Voor de daytrade...
    De minimale trade die je kunt doen is de 1 $, want daar zal het heel snel op staan!
    Zelf verwacht ik bij gelijke cijfers voor komende kwartalen dat het makkelijk weer naar 3 dollar kan!
    Daarnaast gaan ze hun vierde productiebedrijf in Q1 weer opstarten, ook
    dat zal alleen maar de omzet/winst verhogen!
    Het zou zomaar weer een 5 tot 8 dollar aandeel kunnen worden binnen nu en 1 a 2 jaar!
  12. [verwijderd] 2 november 2011 16:33
    Als PEIX de net earnings per kwartaal kan doortrekken dan komen ze minimaal op $1 winst p/a uit in 2012.
    En debt free!!!!!

    Dan zou een koers van minimaal $8 en maximaal $14 in 2012 mogelijk moeten zijn.

    Nu te koop voor $0.46.
6.395 Posts
Pagina: «« 1 ... 6 7 8 9 10 ... 320 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.018
AB InBev 2 5.501
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.677
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 265
Accsys Technologies 23 10.702
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 189
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.752
Aedifica 3 916
Aegon 3.258 322.852
AFC Ajax 538 7.088
Affimed NV 2 6.297
ageas 5.844 109.893
Agfa-Gevaert 14 2.050
Ahold 3.538 74.339
Air France - KLM 1.025 35.047
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.041
Alfen 16 24.858
Allfunds Group 4 1.473
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.248
AMG 971 133.366
AMS 3 73
Amsterdam Commodities 305 6.690
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.007
Apollo Alternative Assets 1 17
Apple 5 382
Arcadis 252 8.778
Arcelor Mittal 2.033 320.714
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.302
Aroundtown SA 1 219
Arrowhead Research 5 9.740
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.134
ASML 1.766 107.454
ASR Nederland 21 4.486
ATAI Life Sciences 1 7
Atenor Group 1 491
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.673
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392